The North America Moist Wound Dressings Market would witness market growth of 4.8% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 429.0 million Units, showcasing a growth of 4.5% (2019-2022).
Calcium salt and sodium alginic acid create alginate dressings in flexible filaments and foams. Due to their non-stickiness and porosity, alginate dressings can absorb surplus wound secretions up to twenty times their weight. Hydrogel dressings are composed of insoluble, hydrophilic, and often gel- and film-based materials. These dressings contain 70 to 90% water, allowing them to absorb many ulcers. These dressings have several applications, including skin tears, surgical incisions, burns, and pressure ulcers.
Various company initiatives, such as business expansion, product introductions, and acquisitions, are anticipated to generate substantial growth opportunities. Advanced wound dressings emit pharmaceutically active ingredients to accelerate healing and reduce pain and inflammation. Care for wounds is essential to expedite the healing process and reduce the risk of infection. The increasing prevalence of diabetic pressure, venous stagnation, and foot ulcers are among the main factors driving the market growth.
The adoption of moist wound dressings in North America has been significant and continues to grow. North America, including the United States and Canada, has a substantial population with chronic health conditions such as diabetes, vascular diseases, and obesity, all of which increase the risk of chronic wounds like diabetic ulcers and pressure ulcers. As the prevalence of diabetes increases, the market will expand as diabetes can impair the body's natural wound-healing processes due to factors such as reduced blood flow, neuropathy (nerve damage), and compromised immune function. As a result, individuals with diabetes are more likely to experience slow or non-healing wounds, necessitating advanced wound care solutions like moist dressings. Therefore, the region will present lucrative growth prospects for the expansion of the market throughout the forecast period.
The US market dominated the North America Moist Wound Dressings Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.8 billion by 2030. The Canada market is poised to grow at a CAGR of 7.1% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 6.2% during (2023 - 2030).
Based on Application, the market is segmented into Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others), and Acute Wounds (Surgical & Traumatic Wounds, and Burns). Based on End-use, the market is segmented into Hospitals, Specialty Clinics, Home Healthcare, and Others. Based on Product, the market is segmented into Foam Dressings, Film Dressings, Hydrogel Dressings, Alginate Dressings, Hydrocolloid Dressings, Collagen Dressings, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Moist Wound Dressings Market is Predict to reach $6.2 Billion by 2030, at a CAGR of 5.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Coloplast Group, Medline Industries, Inc., Smith & Nephew PLC, Convatec, Inc., Essity AB, Integra LifeSciences Holdings Corporation, Cardinal Health, Inc., Molnlycke Health Care AB, 3M Company, B. Braun Melsungen AG
By Application (Volume, Million Units, USD Million, 2019-2030)
By End-use (Volume, Million Units, USD Million, 2019-2030)
By Product (Volume, Million Units, USD Million, 2019-2030)
By Country (Volume, Million Units, USD Million, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
